Omega Diagnostics Gp - Directorate Change

Cambridge Nutritional Sciences

22/08/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230822:nRSV9840Ja&default-theme=true

RNS Number : 9840J  Omega Diagnostics Group PLC  22 August 2023

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega", the "Company" or the "Group")

 

Directorate Change

 

Omega (AIM: ODX), the specialist medical diagnostics company focused on
industry-leading Health and Nutrition products, announces that Chris Lea,
Group Finance Director of the Company, will be stepping down as a Director and
leaving the Company with immediate effect.

 

Chris has been instrumental in selling the Alva site and subsequent sale of
the CD4 Business along with a restructuring of Omega, based in Ely,
Cambridgeshire. The restructuring and disposals were key in refocusing the
Company on food intolerance testing and ensuring it has sufficient resources
to drive Omega forward. Chris is based in Scotland and his stepping down is in
line with the Company strategy to focus more of its resources in and around
the Company's headquarters in Ely, Cambridge.

 

As per the recent results, the Company remains very well-funded with £5.1m of
cash at 31 March 2023. This is more than sufficient to build on the platform
Omega has to drive a profitable and sustainable Company.

 

Omega intends to change its name to Cambridge Nutritional Sciences at the
upcoming Annual General Meeting and intends to appoint an interim CFO shortly.

 

Simon Douglas, Chairman of Omega, said: "We thank Chris for all his efforts
and fully appreciate how instrumental he was in the refocusing and
restructuring of the Company. We wish him all the best for the future."

 

 

Contacts:

 

 Omega Diagnostics Group PLC                                www.omegadx.com (http://www.omegadx.com/)
 Jag Grewal, Chief Executive Officer                        via Walbrook PR

 finnCap Ltd                                                Tel: 020 7220 0500
 Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)
 Nigel Birks/Harriet Ward (ECM)

 Walbrook PR Limited             Tel: 020 7933 8780 or omega@walbrookpr.com (mailto:omega@walbrookpr.com)
 Paul McManus                    Mob: 07980 541 893
 Lianne Applegarth               Mob: 07584 391 303
 Sam Allen                       Mob: 07502 558 258

 

About Omega Diagnostics Group PLC

Omega manufactures and distributes high quality in-vitro diagnostic products
for use in hospitals, clinics, laboratories and healthcare practitioners in
over 85 countries and is now focused on the health and nutrition
sector.www.omegadx.com (http://www.omegadx.com/)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAPPUPWRUPWGQG